Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized treatment with atypical antipsychotic medications.

Advances in therapy - 1 Jan 2000

Kim Edward, Levy Richard, Pikalov Andrei

Abstract excerpt

The considerable pharmacologic differences among atypical antipsychotic agents and the specific clinical circumstances of individual patients with psychiatric illness require the availability of a full range of agents in this class. Restrictions in the availability of atypical agents may prove to be counterproductive, both clinically and economically. Elderly individuals and those from minority groups may be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Cost-Benefit Analysis
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP3A

Share to Cytochrome P-450 Enzyme System

Share to Drug Interactions

Share to Minority Groups

Share to Patient Compliance

Source

Identifiers

PMID: 17901022
DOI: 10.1007/BF02849966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized treatment with atypical antipsychotic medications.PMID 17901022Read ↗

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.Semantic proximity Read ↗

Pharmacogenetics of antipsychotics: Clinical utility and implementationSemantic proximity Read ↗

The Dosing of Atypical AntipsychoticsSemantic proximity Read ↗

Personalized antipsychotic treatment: the adverse effects perspectives.Semantic proximity Read ↗

Pharmacogenetics of Response to Antipsychotics in Patients with SchizophreniaSemantic proximity Read ↗

The future (or lack of future) of personalized prescription in psychiatrySemantic proximity Read ↗

The impact of pharmacogenetics on the development and use of antipsychotic drugs.Semantic proximity Read ↗

Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.Semantic proximity Read ↗

Prescribing trends for the same patients with schizophrenia over 20 yearsSemantic proximity Read ↗

Identifying a predictive model for response to atypical antipsychotic monotherapy treatment in south Indian schizophrenia patients.Semantic proximity Read ↗

Atypical antipsychotic (AAP)-induced metabolic toxicity : study of mechanisms, biomarkers and reversal strategiesSemantic proximity Read ↗

Mechanisms of action of atypical antipsychotic drugsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.